UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  May 21, 2015

 

ROCKWELL MEDICAL, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Registrant’s telephone number, including area code            (248) 960-9009

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 5.02                                           Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On May 21, 2015, Rockwell Medical, Inc. (the “Company”) held its Annual Meeting of Shareholders.  At the Annual Meeting, as noted in Item 5.07 below, the shareholders approved an amendment of the Company’s Amended and Restated 2007 Long Term Incentive Plan, as amended (the “LTIP”), which had been previously approved by the Board of Directors of the Company subject to shareholder approval.  Among other things, the amendment increases the total number of common shares subject to the LTIP from 9,500,000 shares to 11,500,000 shares.

 

Item 5.07                                           Submission of Matters to a Vote of Security Holders.

 

At the Company’s Annual Meeting of Shareholders on May 21, 2015, the shareholders voted to (1) reelect two incumbent directors for a term expiring in 2018, (2) approve the amendment of the LTIP increasing the number of shares available for grants, and (3) ratify the selection of Plante & Moran, PLLC as the Company’s independent registered public accounting firm for 2015.  The following tables set forth the final voting results on each matter.

 

Director Nominee		For		Withheld		Broker Non-Votes
Robert Chioini		13,992,417		3,663,082		25,313,617
Patrick Bagley		13,629,380		4,026,119		25,313,617

 

Proposal		For		Against		Abstain		Broker Non- Votes
Approve amendment of LTIP		10,310,242		6,224,242		1,121,015		25,313,617
Ratify the selection of Plante & Moran, PLLC		42,413,369		328,215		227,532		—

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

	ROCKWELL MEDICAL, INC.
Date: May 28, 2015	By:	/s/ Thomas E. Klema
		Thomas E. Klema
		Its: Chief Financial Officer

 

3